Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1955 1
1965 1
1966 4
1967 5
1968 6
1969 1
1970 3
1971 5
1972 4
1973 8
1974 6
1975 3
1976 7
1977 2
1978 3
1979 1
1980 2
1981 5
1982 4
1983 10
1984 7
1985 5
1986 7
1987 7
1988 16
1989 4
1990 9
1991 5
1992 7
1993 8
1994 10
1995 7
1996 6
1997 6
1998 14
1999 12
2000 7
2001 16
2002 10
2003 15
2004 12
2005 16
2006 20
2007 20
2008 18
2009 22
2010 33
2011 35
2012 27
2013 20
2014 18
2015 30
2016 39
2017 28
2018 30
2019 43
2020 39
2021 29
2022 29
2023 26
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

743 results

Results by year

Filters applied: . Clear all
Page 1
Epidermolysis bullosa acquisita.
Miyamoto D, Gordilho JO, Santi CG, Porro AM. Miyamoto D, et al. An Bras Dermatol. 2022 Jul-Aug;97(4):409-423. doi: 10.1016/j.abd.2021.09.010. Epub 2022 Jun 11. An Bras Dermatol. 2022. PMID: 35701269 Free PMC article.
Epidermolysis bullosa acquisita is a rare autoimmune disease, characterized by the synthesis of anti-collagen VII autoantibodies, the main component of hemidesmosome anchoring fibrils. ...There is no specific therapy for epidermolysis bullosa acquisita
Epidermolysis bullosa acquisita is a rare autoimmune disease, characterized by the synthesis of anti-collagen VII autoantibodi
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
Guide SV, Gonzalez ME, Bağcı IS, Agostini B, Chen H, Feeney G, Steimer M, Kapadia B, Sridhar K, Quesada Sanchez L, Gonzalez F, Van Ligten M, Parry TJ, Chitra S, Kammerman LA, Krishnan S, Marinkovich MP. Guide SV, et al. N Engl J Med. 2022 Dec 15;387(24):2211-2219. doi: 10.1056/NEJMoa2206663. N Engl J Med. 2022. PMID: 36516090 Clinical Trial.
BACKGROUND: Dystrophic epidermolysis bullosa is a rare genetic blistering skin disease caused by mutations in COL7A1, which encodes type VII collagen (C7). ...METHODS: We conducted a phase 3, double-blind, intrapatient randomized, placebo-controlled trial
BACKGROUND: Dystrophic epidermolysis bullosa is a rare genetic blistering skin disease caused by mutations in COL7A1, which en …
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
Gurevich I, Agarwal P, Zhang P, Dolorito JA, Oliver S, Liu H, Reitze N, Sarma N, Bagci IS, Sridhar K, Kakarla V, Yenamandra VK, O'Malley M, Prisco M, Tufa SF, Keene DR, South AP, Krishnan SM, Marinkovich MP. Gurevich I, et al. Nat Med. 2022 Apr;28(4):780-788. doi: 10.1038/s41591-022-01737-y. Epub 2022 Mar 28. Nat Med. 2022. PMID: 35347281 Free PMC article. Clinical Trial.
Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis associated with blistering, wounding, and scarring caused by mutations in COL7A1, the gene encoding the anchoring fibril component, collagen VII (C7). ...B-VEC restored C7 expression in R …
Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis associated with blistering, wounding, and scarr …
Gene Therapy for Epidermolysis Bullosa.
Marinkovich MP, Tang JY. Marinkovich MP, et al. J Invest Dermatol. 2019 Jun;139(6):1221-1226. doi: 10.1016/j.jid.2018.11.036. Epub 2019 May 5. J Invest Dermatol. 2019. PMID: 31068252 Free article. Review.
Epidermolysis bullosa is a family of diseases characterized by blistering and fragility of the skin in response to mechanical trauma. Advances in our understanding of epidermolysis bullosa pathophysiology have provided the necessary foundation for the
Epidermolysis bullosa is a family of diseases characterized by blistering and fragility of the skin in response to mechanical
Epidermolysis bullosa acquisita.
Kim JH, Kim SC. Kim JH, et al. J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1204-13. doi: 10.1111/jdv.12096. Epub 2013 Feb 1. J Eur Acad Dermatol Venereol. 2013. PMID: 23368767 Review.
Epidermolysis bullosa acquisita (EBA) is a chronic autoimmune subepidermal bullous disease with clinical features similar to the genetic form of dystrophic epidermolysis bullosa. EBA is characterized by the presence of autoantibodies against typ
Epidermolysis bullosa acquisita (EBA) is a chronic autoimmune subepidermal bullous disease with clinical features simil
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.
Kern JS, Sprecher E, Fernandez MF, Schauer F, Bodemer C, Cunningham T, Löwe S, Davis C, Sumeray M, Bruckner AL, Murrell DF; EASE investigators. Kern JS, et al. Br J Dermatol. 2023 Jan 23;188(1):12-21. doi: 10.1093/bjd/ljac001. Br J Dermatol. 2023. PMID: 36689495 Clinical Trial.
BACKGROUND: Epidermolysis bullosa (EB) is a heterogeneous group of rare, difficult-to-treat, inherited multisystem diseases affecting epithelial integrity. ...METHODS: Patients with dystrophic EB, junctional EB or Kindler EB and a target partial-thickness wound last …
BACKGROUND: Epidermolysis bullosa (EB) is a heterogeneous group of rare, difficult-to-treat, inherited multisystem diseases af …
Epidermolysis bullosa acquisita.
Gupta R, Woodley DT, Chen M. Gupta R, et al. Clin Dermatol. 2012 Jan-Feb;30(1):60-9. doi: 10.1016/j.clindermatol.2011.03.011. Clin Dermatol. 2012. PMID: 22137228 Free PMC article. Review.
Epidermolysis bullosa acquisita (EBA) is a rare, acquired, chronic subepidermal bullous disease of the skin and mucosa characterized by autoantibodies to type VII collagen (C7) structures, a major component of anchoring fibrils, which attach the epidermis to the der
Epidermolysis bullosa acquisita (EBA) is a rare, acquired, chronic subepidermal bullous disease of the skin and mucosa charact
Pediatric epidermolysis bullosa acquisita: A review.
Hignett E, Sami N. Hignett E, et al. Pediatr Dermatol. 2021 Sep;38(5):1047-1050. doi: 10.1111/pde.14722. Epub 2021 Aug 2. Pediatr Dermatol. 2021. PMID: 34339066 Review.
Epidermolysis bullosa acquisita (EBA) is an acquired autoimmune blistering skin disorder that is rare in adults and even rarer in childhood. This review aims to identify cases of pediatric EBA and report their clinical features and course. Our literature revi
Epidermolysis bullosa acquisita (EBA) is an acquired autoimmune blistering skin disorder that is rare in adults and even rarer
Drug Development in Pemphigoid Diseases.
Bieber K, Ludwig RJ. Bieber K, et al. Acta Derm Venereol. 2020 Feb 12;100(5):adv00055. doi: 10.2340/00015555-3400. Acta Derm Venereol. 2020. PMID: 32039458 Free PMC article. Review.
While the diagnostics of pemphigoid diseases and insights into their pathogenesis have improved significantly, the development of novel treatments that are effective and safe remains an unmet medical need. However, numerous pre-clinical studies and early clinical tr …
While the diagnostics of pemphigoid diseases and insights into their pathogenesis have improved significantly, the development of novel trea …
Epidermolysis bullosa: Advances in research and treatment.
Prodinger C, Reichelt J, Bauer JW, Laimer M. Prodinger C, et al. Exp Dermatol. 2019 Oct;28(10):1176-1189. doi: 10.1111/exd.13979. Epub 2019 Aug 8. Exp Dermatol. 2019. PMID: 31140655 Free PMC article. Review.
Epidermolysis bullosa (EB) is the umbrella term for a group of rare inherited skin fragility disorders caused by mutations in at least 20 different genes. ...This review discusses molecular procedures currently under investigation at the EB House Austria, a designat
Epidermolysis bullosa (EB) is the umbrella term for a group of rare inherited skin fragility disorders caused by mutations in
743 results